Symptom Presentations

Root Causes

Treatment for Remission

Immune System

Cytokine reactions are “immune” reactions. The immune system works with “immunity”. It acts to protect the body from pathogens that invade the body. When the body becomes overloaded with pathogens, the immune system senses there is something wrong. It then triggers histamine reactions, mast cell activation syndrome reactions and or cytokine reactions.

Cytokine Reactions – Symptoms

Cytokine reaction symptoms (immune reactions) can present with inflammation, joint pain, fatigue, insomnia, digestive challenges, abdominal pain, brain fog, memory loss, chronic sinusitis, allergies, food sensitivities, vertigo, dizziness, hair loss, tinnitus, vision loss, intermittent difficulty swallowing, intermittent fevers, intermittent night sweats, AFIB, skipped heart beats, intermittent skin rashes, intermittent pain in the area of the left chest region, burning pain in various parts of the body, sciatica, chronic pain in the back of the neck and or shoulder, chronic migraines, intermittent gripping chest pains, intermittent ear pain, intermittent numbness and tingling, bleeding gums, mental/emotional challenges such as bipolar/schizophrenic disorders, urinary restriction, pain in the perineum, and more. Cytokine reactions can also present with degeneration of the tissues, whether bone, tendon, cartilage, tendon, muscle, vascular tissue, nervous system tissue, organ tissue and skin.

Mechanisms of Cytokine Reactions

These reactions are triggered by cytokine responses (immune responses), otherwise known as interleukin responses. Interleukins are a class of glycoproteins produced by leukocytes for regulating immune response. There are different types and different classifications of interleukin responses. Interleukin 6 or IL-6 corresponds to inflammation, cardiovascular inflammation and induces the synthesis of fibrinogen, helpcidin and hepatocytes. This can cause numerous autoimmune related challenges. Interleukin 1 or IL-1 response triggers fevers, loss of hearing, neurological symptoms, conjunctivitis, arthritis and more. Disregulation of Il-10 is common with acute and chronic infections. IL-10 prevents autoimmune presentations from manifesting. With an increase of pathogenic presence in the body, Il-10 becomes disregulated thus manifesting with the potential of IBD, IBS, rheumatoid arthritis, psoriasis, lupus multiple sclerosis, cancer and more. These are just a few of the interleukin categories that are associated with symptom presentations. That said, when we have chronic symptoms, there are explanations for them!

The Cycle of Life

Every living creature has parasites, bacteria, fungus, spirochetes and molds that live within us. Many times at a manageable level. Other times pathogenic levels get to the point when they are not manageable anymore. Pathogens are the main cause of degeneration, disease and death.

Pathogenic Transmission

We are born with pathogens. They are passed down from the mother in utero; most times not enough to cause health challenges until far down the road; although, sometimes sooner than later, depending on the mother and the type of stress or trauma the child has. We gather pathogens from food, from the air we breathe, water, mud, water sources such as lakes river and streams, insect and animal bites, from kissing, physical intimacy, animals such as dogs licking mucus membranes such as the eyes, nose and mouth, etc. Pathogens are the main cause of degeneration.

Pathogenic Proliferation

Depending on our lifestyle, stress, genetics, history of trauma, hygiene and exposure, depends on how the body keeps pathogens under control or allows pathogens to become too much for the immune system to handle. When the body has excess stress, the immune system becomes compromised and cannot keep pathogens under control as easily. Thus existing pathogens take the opportunity to proliferate. When people have a history of trauma, the immune system becomes compromised and existing pathogens many times proliferate to symptomatic levels. When people are chronically angry, the immune system becomes compromised and pathogens proliferate. When people have a poor diet, pathogens proliferate. When existing pathogens become too much for the immune system to handle, the body begins to develop chronic immune symptoms. Most of which seem unrelated, when most are in fact related. As animals and people age, the body has less energy, the immune system slows down and pathogens build up. When we have an overload of pathogenic build-up, the immune system becomes compromised, thus allowing ourselves to become an open door for other pathogens to enter the body, set up camp, proliferate and cause problems.

Assist Immune Function and Suppress Cytokine Reactions

Chronic symptoms let us know there may be something very wrong with our IMMUNE SYSTEM. It may be telling us to assist the body with immune function, because we have an excess of pathogen, too much or the body to handle. NOT to suppress our immune system.

When the body’s immune system cannot keep up with immune function, medical intervention is needed to assist the immune system to do its job. This is where herbs come in. The right herbs can assist the immune system with immune function as well help the body reduce immune reactions, thus reducing symptoms while addressing the root cause.

Pathogenic Intelligence

Pathogens are in a constant state of flux. At a single cell level, the protein molecule of a single cell pathogen is constantly changing. Once the body’s antibodies identifies a pathogen, the pathogen can morph, change form, replicate its DNA close to the DNA of our own human body. Antibodies many times cannot identify the pathogen anymore, thus causing the body’s antibodies to go after its own tissues. This becomes an autoimmune disorder. This is when many doctors believe we have a genetic disposition for certain illnesses and there is no turning back. Instead doctors provide medications to keep immune reactions at bay while the disease gets worse.

Triggers of Cytokine Reactions

In manageable chronic symptomatic cases, cytokine reactions can be held at bay with dietary modifications, exercise/movement restrictions and stress management.

Cytokine Reaction Triggers – Dietary Triggers

Foods that metabolize as polysaccharides, such as any type of sweetener except stevia, honey, all dairy, vinegars, alcohol, red meat (has a polysaccharide called alpha galactosidase) and more, may excite pathogens and or interact with pathogenic toxins in the body. When this happens, the immune system becomes overactive because of the pathogenic systemic response. These responses generate cytokine reactions. With the abstention of certain foods, cytokine reactions and unpleasant symptoms can be held at bay.

People who are more debilitated and high very high levels of pathogens may have symptoms all the time regardless of dietary modifications

Cytokine Reaction Triggers – Exercise and Certain Movements

Exercise can loosen up pathogens in the body, thus triggering systemic responses and cytokine reactions in people with relatively high pathogenic loads. People who have high pathogenic loads, can be taken past what is referred to as tipping points with just certain movements, depending on the location of the pathogenic load. For example, in people with a high pathogenic load in the abdominal area, whether it be in the fascia, nerve sheaths or vascular tissue. When a person in this predicament performs a simple back-bend, an inflammatory cascade can take place in the abdomen, thus causing a delayed response of extreme abdominal pain that can lead to bowel obstruction. There won’t be anything obstructing the bowel, however bowel sounds and peristalsis may cease. This may begin with inflammation, extreme pain, peritonitis and loss of movement in the bowel. This is a life threatening emergency that can lead to a perforated bowel and death.

Cytokine Reaction Triggers – Stress & Anger

Stress and anger can stop the function of the immune system. When the immune system is at a standstill, pathogens get excited. When pathogens get excited, the immune system then gets triggered and stimulates an immune response leading to cytokine reactions such as any of the symptoms previously discussed.

How to keep Cytokine Reactions Under Control

Dietary modifications with the Lyme disease diet. The Lyme disease diet applies to cytokine reactions whether one has Lyme disease or not.

Exercise abstention or moderation – Depending on the pathogenic load may depend on how much or how little cytokine reactions are triggered by exercise. Remember to expect the potential for symptomatic delays from 24- 48 hours before symptoms manifest after exercise.

Stress and anger – Keep the anger at a minimum. If you get angry, consider keeping it at bay. Getting angry will likely not help the situation anyway. Manage stress as it will never help either. Consider breathing exercises throughout the day, short meditations and or periods of affirmations.

Take herbal formulas to help the body with immune function. I use Spiro-Clear and Intra-Cell. These two formulas create an environment int he body unstable for the survival of all categories of pathogens.

Chinese Herbal Medicine – Herbs in Chinese herbal formulas created by Trillium Health Solutions have been studied in the lab as well clinically. They are shown to suppress immune cytokine reactions. 1000’s of studies have been done on these herbs and have been shown effective against, pharmaceutical resistant candida, Lyme disease, Bartonella, Babesia, malarial infections, parasites, molds, fungi and spirochetes and more. The rotation of of the Intra-Cell formulas are made to offset the potential of bacterial resistance.

When dietary modifications, exercise modifications and stress management is considered, immune reactions can be held at bay. When immune reactions are held at bay, the right herbal formulas can help the body reverse the core issue of cytokine reactions and put chronic cytokine reactions and autoimmune disease in complete remission.

Few of the Many References Available for this Article

  1. Kindler W, Wolf H, Thier K, Oberndorfer S. Peripheral facial palsy as an initial symptom of Lyme neuroborreliosis in an Austrian endemic area. Wiener Klinische Wochenschrift. 2016;128(21-22):837-840. 
  2. Dumic I, Vitorovic D, Spritzer S, Sviggum E, Patel J, Ramanan P. Acute transverse myelitis – A rare clinical manifestation of Lyme neuroborreliosis. Idcases. 2018;15:e00479. doi:10.1016/j.idcr.2018.e00479.
  3. Olivares JP, Pallas F, Ceccaldi M, et al. Lyme disease presenting as isolated acute urinary retention caused by transverse myelitis: an electrophysiological and urodynamical study. Archives Of Physical Medicine And Rehabilitation. 1995;76(12):1171-1172. 
  4. Khairallah M, Jelliti B, Jenzeri S. Emergent Infectious Uveitis. Middle East African Journal of Ophthalmology. 2009;16(4):225-238. doi:10.4103/0974-9233.58426.
  5. Leys AM, Schönherr U, Lang GE, et al. Retinal vasculitis in Lyme borreliosis. Bulletin De La Societe Belge D’ophtalmologie. 1995;259:205-214.
  6. Dobbe ASM, Zoethout AC, Bleeker WA, Oenema DG. [Acute abdominal pain caused by neuroborreliosis]. Nederlands Tijdschrift Voor Geneeskunde. 2018;162.
  7. Verma V, Roman M, Shah D, Zaretskaya M, Yassin MH. A case of chronic progressive Lyme encephalitis as a manifestation of late Lyme neuroborreliosis. Infectious Disease Reports. 2014;6(4):51-54. doi:10.4081/idr.2014.5496.
  8. Squires S. Diseases doctors miss. Woman’s Day. 1995;58(9):94.
  9. Fesler MC, Middelveen MJ, Burke JM, Stricker RB. Erosive Vulvovaginitis Associated With Borrelia burgdorferi Infection. Journal Of Investigative Medicine High Impact Case Reports. 2019;7:2324709619842901. doi:10.1177/2324709619842901.
  10. Deresinski S. Sudden Unexpected Cardiac Death from Lyme Disease. (Cover story). Infectious Disease Alert. 2014;33(4):37-39.
  11. Dupeyron, A, Lecocq, J, Jaulhac, B, Isner-Horobeti, M-E, Vautravers, P, Cohen-Solal, J, Sordet, C & Kuntz, J-L 2004, ‘Sciatica, disk herniation, and neuroborreliosis. A report of four cases’, Joint, Bone, Spine: Revue Du Rhumatisme, vol. 71, no. 5, pp. 433–437,
  12. Rochlin I, Ninivaggi DV, Benach JL. Malaria and Lyme disease – the largest vector-borne US epidemics in the last 100 years: success and failure of public health. BMC Public Health. 2019;19(1):804. doi:10.1186/s12889-019-7069-6.
  13. Sikutová S, Halouzka J, Mendel J, Knoz J, Rudolf I. Novel spirochetes isolated from mosquitoes and black flies in the Czech Republic. Journal Of Vector Ecology: Journal Of The Society For Vector Ecology. 2010;35(1):50-55. doi:10.1111/j.1948-7134.2010.00027.x.
  14. BIRDS ROLE Loss SR, Noden BH, Hamer GL, Hamer SA. A quantitative synthesis of the role of birds in carrying ticks and tick-borne pathogens in North America. Oecologia. 2016;182(4):947-959. 
  15. Moutailler S, Valiente Moro C, Vaumourin E, et al. Co-infection of Ticks: The Rule Rather Than the Exception. Plos Neglected Tropical Diseases. 2016;10(3):e0004539. doi:10.1371/journal.pntd.0004539.
  16. Scholl DC, Embers ME, Caskey JR, et al. Immunomodulatory effects of tick saliva on dermal cells exposed to Borrelia burgdorferi, the agent of Lyme disease. Parasites & Vectors. 2016;9:1-17. doi:10.1186/s13071-016-1638-7.
  17. Sharareh N, Behler RP, Roome AB, Shepherd J, Garruto RM, Sabounchi NS. Risk Factors of Lyme Disease: An Intersection of Environmental Ecology and Systems Science. Healthcare (Basel, Switzerland). 2019;7(2). doi:10.3390/healthcare7020066.
  18. Krause PJ, Hendrickson JE, Steeves TK, Fish D. Blood transfusion transmission of the tick-borne relapsing fever spirochete Borrelia miyamotoi in mice. Transfusion. 2015;55(3):593-597. doi:10.1111/trf.12879.
  19. Bhanot P, Parveen N. Investigating disease severity in an animal model of concurrent babesiosis and Lyme disease. International Journal for Parasitology. 2019;49(2):145-151. doi:10.1016/j.ijpara.2018.06.006.
  20. Johnson SE, Swaminathan B, Moore P, Broome CV, Parvin M. Borrelia burgdorferi: survival in experimentally infected human blood processed for transfusion. The Journal Of Infectious Diseases. 1990;162(2):557-559. 
  21. Teal TH, Chapman M, Guillemette T, Margulis L. Free-living spirochetes from Cape Cod microbial mats detected by electron microscopy. Microbiologia (Madrid, Spain).
  22. Middelveen MJ, Burke J, Sapi E, et al. Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions. F1000research. 2014;3:309. doi:10.12688/f1000research.5778.3.
  23. Schlesinger PA, Duray PH, Burke BA, Steere AC, Stillman MT. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Annals Of Internal Medicine. 1985;103(1):67-68. 
  24. Woods JL. Syphilis in Arkansas adolescents: a high-risk infection for a high-risk group. The Journal Of The Arkansas Medical Society. 2010;106(8):182-184.
  25. Schmidt BL, Aberer E, Stockenhuber C, Klade H, Breier F, Luger A. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis. Diagnostic Microbiology And Infectious Disease. 1995;21(3):121-128. 
  26. Zhou P, Qian Y, Lu H, Guan Z. Nonvenereal transmission of syphilis in infancy by mouth-to-mouth transfer of prechewed food. Sexually Transmitted Diseases. 2009;36(4):216-217. doi:10.1097/OLQ.0b013e3181901c79.
  27. Nieto-Patlán A, Campillo-Navarro M, Rodríguez-Cortés O, et al. Recognition of Candida albicans by Dectin-1 induces mast cell activation. Immunobiology. 2015;220(9):1093-1100. doi:10.1016/j.imbio.2015.05.005.
  28. Theoharides TC, Kavalioti M. Stress, inflammation and natural treatments. Journal Of Biological Regulators And Homeostatic Agents. 2018;32(6):1345-1347.
  29. Peters EMJ, Michenko A, Kupfer J, et al. Mental stress in atopic dermatitis–neuronal plasticity and the cholinergic system are affected in atopic dermatitis and in response to acute experimental mental stress in a randomized controlled pilot study. Plos One. 2014;9(12):e113552. doi:10.1371/journal.pone.0113552.
  30. Alevizos M, Karagkouni A, Panagiotidou S, Vasiadi M, Theoharides TC. Stress triggers coronary mast cells leading to cardiac events. Annals Of Allergy, Asthma & Immunology: Official Publication Of The American College Of Allergy, Asthma, & Immunology. 2014;112(4):309-316. doi:10.1016/j.anai.2013.09.017.
  31. BURKLUND M. RECHARGE YOUR immune system. Better Nutrition. 2019;81(10):26-30. 
  32. Priyadarsini A. C., Rohini NS. Pranayama for the management of depression and enhancement of resilience. Indian Journal of Positive Psychology. 2017;8(3):351-355.
  33. SWAMY KANAN K. Effectiveness of Pranayama on Depression and Anxiety in Elderly: A Systematic Review. Baba Farid University Nursing Journal. 2013;5(2):4-11.
  34. Trinh H, Yoo Y, Won K-H, et al. Evaluation of in-vitro antimicrobial activity of Artemisia  apiacea H. and Scutellaria baicalensis G. extracts. Journal Of Medical Microbiology. 2018;67(4):489-495. doi:10.1099/jmm.0.000709.
  35. ARITULUK ZC, KOÇAK CÖ, RENDA G, EKİZOĞLU M, EZER N. Antimicrobial activity of three Scutellaria L. species from Turkey. Marmara Pharmaceutical Journal. 2019;23(3):552-558. doi:10.12991/jrp.2019.162.
  36. Franzblau SG, Cross C. Comparative in vitro antimicrobial activity of Chinese medicinal herbs. Journal Of Ethnopharmacology. 1986;15(3):279-288.
  37. Zhang C, Sheng J, Sarsaiya S, et al. The anti-diabetic activities, gut microbiota composition, the anti-inflammatory effects of Scutellaria–coptis herb couple against insulin resistance-model of diabetes involving the toll-like receptor 4 signaling pathway. Journal of Ethnopharmacology. 2019;237:202-214. doi:10.1016/j.jep.2019.02.040.
  38. Xu Y, Chen X-X, Jiang Y-X, Zhang D-D. Ethyl Acetate Fraction from Hedyotis diffusa plus Scutellaria barbata Exerts Anti-Inflammatory Effects by Regulating miR-155 Expression and JNK Signaling Pathway. Evidence-based Complementary & Alternative Medicine (eCAM). 2018;2018:1-11. doi:10.1155/2018/3593408.
  39. ***** Yubin Lu, Ph.D., L.Ac, Dr. Lu Herbology, Herbs from Root and Rhizomes, Class 48
  40. Bensky, Clavey, Stöger, Gamble, Materia Medica
  41. Sun Y, Lenon GB, Yang AWH. Phellodendri Cortex: A Phytochemical, Pharmacological, and Pharmacokinetic Review. Evidence-based Complementary & Alternative Medicine (eCAM). April 2019:1-45. doi:10.1155/2019/7621929.
  42. da Silva AR, de Andrade Neto JB, da Silva CR, et al. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp. Antimicrobial Agents And Chemotherapy. 2016;60(6):3551-3557. doi:10.1128/AAC.01846-15.
  43. Yu H-H, Kim K-J, Cha J-D, et al. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. Journal Of Medicinal Food. 2005;8(4):454-461
  44. Du Z, Huang Y, Chen Y, Chen Y. Combination effects of baicalin with levofloxacin against biofilm-related infections. American Journal Of Translational Research. 2019;11(3):1270-1281
  45. Wu S-C, Chu X-L, Su J-Q, et al. Baicalin protects mice against Salmonella typhimurium infection via the modulation of both bacterial virulence and host response. Phytomedicine: International Journal Of Phytotherapy And Phytopharmacology. 2018;48:21-31. doi:10.1016/j.phymed.2018.04.063.
  46. Qian K, Kong Z-R, Zhang J, et al. Baicalin is an inhibitor of subgroup J avian leukosis virus infection. Virus Research. 2018;248:63-70. doi:10.1016/j.virusres.2018.02.017.
  47. Rong Q, Xu M, Dong Q, et al. In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori. BMC Complementary And Alternative Medicine. 2016;16(1):331. doi:10.1186/s12906-016-1310-y.
  48. Ahamad J, Toufeeq I, Khan MA, et al. Oleuropein: A natural antioxidant molecule in the treatment of metabolic syndrome. Phytotherapy Research: PTR. November 2019. doi:10.1002/ptr.6511.
  49. Del Ben M, Nocella C, Loffredo L, et al. Oleuropein-enriched chocolate by extra virgin olive oil blunts hyperglycaemia in diabetic patients: Results from a one-time 2-hour post-prandial cross over study. Clinical Nutrition (Edinburgh, Scotland). September 2019. doi:10.1016/j.clnu.2019.09.006.
  50. Li X, Liu Y, Jia Q, LaMacchia V, O’Donoghue K, Huang Z. A systems biology approach to investigate the antimicrobial activity of oleuropein. Journal Of Industrial Microbiology & Biotechnology. 2016;43(12):1705-1717
  51. Qabaha K, Al-Rimawi F, Qasem A, Naser SA. Oleuropein Is Responsible for the Major Anti-Inflammatory Effects of Olive Leaf Extract. Journal Of Medicinal Food. 2018;21(3):302-305. doi:10.1089/jmf.2017.0070.
  52. Roila R, Ranucci D, Valiani A, Galarini R, Servili M, Branciari R. Antimicrobial and anti-biofilm activity of olive oil by-products against Campylobacter spp. isolated from chicken meat. Acta Scientiarum Polonorum Technologia Alimentaria. 2019;18(1):43-52. doi:10.17306/J.AFS.0629.
  53. Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S. Neuroprotective and Cognitive Enhancement Potentials of Baicalin: A Review. Brain Sci. 2018;8(6):104. Published 2018 Jun 11. doi:10.3390/brainsci8060104
  54. Svensson CI. Interleukin-6: a local pain trigger?. Arthritis Res Ther. 2010;12(5):145. doi:10.1186/ar3138
  55. Su XZ, Miller LH. The discovery of artemisinin and the Nobel Prize in Physiology or Medicine. Sci China Life Sci. 2015;58(11):1175–1179. doi:10.1007/s11427-015-4948-7
  56. In the Literature. Clinical Infectious Diseases. 2015;60(10):iii-iv. doi:10.1093/cid/civ159
  57. Gomes C, Martínez-Puchol S, Ruiz-Roldán L, Pons MJ, Del Valle Mendoza J, Ruiz J. Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants. Scientific Reports. 2016;6:33584. doi:10.1038/srep33584.
  58. Goo Y-K, Terkawi MA, Jia H, et al. Artesunate, a potential drug for treatment of Babesia infection. Parasitology International. 2010;59(3):481-486. doi:10.1016/j.parint.2010.06.004.
  59. Matsuu A, Yamasaki M, Xuan X, Ikadai H, Hikasa Y. In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Veterinary Parasitology. 2008;157(1/2):1-8. doi:10.1016/j.vetpar.2008.07.023.
  60. Loo CSN, Lam NSK, Yu D, Su X, Lu F. Artemisinin and its derivatives in treating protozoan infections beyond malaria. Pharmacological Research. 2017;117:192-217. doi:10.1016/j.phrs.2016.11.012.
  61. https://apps.who.int/iris/bitstream/handle/10665/162441/9789241549127_eng.pdf;jsessionid=C8B8EEECDDD5586BDE90C08F06698D85?sequence=1
  62. Chen J-X, Ji B, Lu Z-L, Hu L-S. Effects of chai hu (radix burpleuri) containing formulation on plasma beta-endorphin, epinephrine and dopamine on patients. The American Journal Of Chinese Medicine. 2005;33(5):737-745. 
  63. SMEJKAL F. [Laboratory tests with 2 anti-influenzal preparations–flumidine and injectio bupleuri (Chai-hu)]. Casopis Lekaru Ceskych. 1962;101:1348-1353.
  64. Tu T-H, Liou D-Y, Lin D-Y, et al. Characterizing the Neuroprotective Effects of S/B Remedy (Scutellaria baicalensis Georgi and Bupleurum scorzonerifolfium Willd) in Spinal Cord Injury. Molecules (Basel, Switzerland). 2019;24(10). doi:10.3390/molecules24101885.
  65. Laouer H, Hirèche-Adjal Y, Prado S, et al. Chemical composition and antimicrobial activity of essential oil of Bupleurum montanum and B. plantagineum. Natural Product Communications. 2009;4(11):1605-1610. 
  66. Mostaqim S, Saha SK, Hani U, et al. Antibacterial Activities of Clove (Syzygium aromaticum) Extracts Against Three Food Borne Pathogens: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. Mymensingh Medical Journal: MMJ. 2019;28(4):779-791
  67. Abdali H, Ajji A. Development of antibacterial structures and films using clove bud powder. Industrial Crops & Products. 2015;72:214-219. doi:10.1016/j.indcrop.2014.09.050.
  68. Begum S, Sara, Tauseef S, et al. In vitro Antibacterial and Antifungal Activity of Flower Buds (Clove) of Syzygium aromaticum. Journal of the Chemical Society of Pakistan. 2014;36(4):723-727.
  69. Pathirana HNKS, Wimalasena SHMP, De Silva BCJ, Hossain S, Heo Gang-Joon. ANTIBACTERIAL ACTIVITY OF CLOVE ESSENTIAL OIL AND EUGENOL AGAINST FISH PATHOGENIC BACTERIA ISOLATED FROM CULTURED OLIVE FLOUNDER (Paralichthys olivaceus). Slovenian Veterinary Research. 2019;56(1):31-38. doi:10.26873/SVR-590-2018
  70. Liu H, Schmitz JC, Wei J, et al. Clove extract inhibits tumor growth and promotes cell cycle arrest and apoptosis. Oncology Research. 2014;21(5):247-259. doi:10.3727/096504014X13946388748910.
  71. Zhang Y, Wang Y, Zhu X, Cao P, Wei S, Lu Y. Antibacterial and antibiofilm activities of eugenol from essential oil of Syzygium aromaticum (L.) Merr. & L. M. Perry (clove) leaf against periodontal pathogen Porphyromonas gingivalis. Microbial Pathogenesis. 2017;113:396-402. doi:10.1016/j.micpath.2017.10.054.
  72. Xu J-G, Liu T, Hu Q-P, Cao X-M. Chemical Composition, Antibacterial Properties and Mechanism of Action of Essential Oil from Clove Buds against Staphylococcus aureus. Molecules (Basel, Switzerland). 2016;21(9). doi:10.3390/molecules21091194.
  73. Yang Pan, Xiahui Wang, Zongning Yin. Synthesis and evaluation of cationic polymeric micelles as carriers of lumbrokinase for targeted thrombolysis. Asian Journal of Pharmaceutical Sciences. 2019;14(2):144-153. doi:10.1016/j.ajps.2018.03.004.
  74. Zhou Y, Wang X, Fan S, He R. A lumbrokinase isozyme targets hepatitis B e-antigen. Science China Life Sciences. 2018;61(12):1596-1598. doi:10.1007/s11427-018-9441-9.
  75. Jiang G, Zhang W, Peng M, Yan W. [Effect of lumbrokinase on patients with acute and moderate risk pulmonary thromboembolism]. Zhong Nan Da Xue Xue Bao Yi Xue Ban = Journal Of Central South University Medical Sciences. 2017;42(10):1156-1162. doi:10.11817/j.issn.1672-7347.2017.10.005.
  76. Asgarpanah J, Kazemivash N. Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L. Chinese Journal Of Integrative Medicine. 2013;19(2):153-159. doi:10.1007/s11655-013-1354-5.
  77. Han S-Y, Li H-X, Ma X, Zhang K, Ma Z-Z, Tu P-F. Protective effects of purified safflower extract on myocardial ischemia in vivo and in vitro. Phytomedicine: International Journal Of Phytotherapy And Phytopharmacology. 2009;16(8):694-702. doi:10.1016/j.phymed.2009.02.019.
  78. Fu H, Wu R, Li Y, et al. Safflower Yellow Prevents Pulmonary Metastasis of Breast Cancer by Inhibiting Tumor Cell Invadopodia. The American Journal Of Chinese Medicine. 2016;44(7):1491-1506
  79. Hajialyani M, Hosein Farzaei M, Echeverría J, Nabavi SM, Uriarte E, Sobarzo-Sánchez E. Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence. Molecules (Basel, Switzerland). 2019;24(3). doi:10.3390/molecules24030648
  80. Sato M, Okuno A, Suzuki K, et al. Dietary intake of the citrus flavonoid hesperidin affects stress-resilience and brain kynurenine levels in a subchronic and mild social defeat stress model in mice. Bioscience, Biotechnology, And Biochemistry. 2019;83(9):1756-1765. doi:10.1080/09168451.2019.1621152.
  81. Raza SS, Khan MM, Ahmad A, et al. Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Research. 2011;1420:93-105. doi:10.1016/j.brainres.2011.08.047.
  82. WARTER PJ, DREZNER HL, HOROSCHAK S. Effect of hesperidin and ascorbic acid on capillary fragility in rheumatoid arthritis; a preliminary report. The Journal Of The Medical Society Of New Jersey. 1946;43:228-230. 
  83. Ohtsuki K, Abe A, Mitsuzumi H, et al. Glucosyl hesperidin improves serum cholesterol composition and inhibits hypertrophy in vasculature. Journal Of Nutritional Science And Vitaminology. 2003;49(6):447-450. 
  84. Youn K, Lee S, Jun M. Discovery of Nobiletin from Citrus Peel as a Potent Inhibitor of β-Amyloid Peptide Toxicity. Nutrients. 2019;11(11). doi:10.3390/nu11112648.
  85. Shi S, Yan H, Chen Y, et al. Pharmacokinetic study of precisely representative antidepressant, prokinetic, anti-inflammatory and anti-oxidative compounds from Fructus aurantii and Magnolia Bark. Chemico-Biological Interactions. October 2019:108851. doi:10.1016/j.cbi.2019.108851.
  86. Lin H-F, Tung K, Chou C-C, Lin C-C, Lin J-G, Tanaka H. Panax ginseng and salvia miltiorrhiza supplementation abolishes eccentric exercise-induced vascular stiffening: a double-blind randomized control trial. BMC Complementary And Alternative Medicine. 2016;16:168. doi:10.1186/s12906-016-1139-4.
  87. Wang L, Ma R, Liu C, et al. Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases. Current Pharmaceutical Design. 2017;23(7):1077-1097. doi:10.2174/1381612822666161010105242.
  88. Qian Q, Qian S, Fan P, Huo D, Wang S. Effect of Salvia miltiorrhiza hydrophilic extract on antioxidant enzymes in diabetic patients with chronic heart disease: a randomized controlled trial. Phytotherapy Research: PTR. 2012;26(1):60-66. doi:10.1002/ptr.3513.
  89. Liu Y, Huang Y, Zhao C, et al. Salvia miltiorrhiza injection on pulmonary heart disease: a systematic review and meta-analysis. The American Journal Of Chinese Medicine. 2014;42(6):1315-1331. doi:10.1142/S0192415X14500827.
  90. Wang L, Li Y, Deng W, et al. Cardio-protection of ultrafine granular powder for Salvia miltiorrhiza Bunge against myocardial infarction. Journal Of Ethnopharmacology. 2018;222:99-106. doi:10.1016/j.jep.2018.04.029.
  91. Yin Q, Lu H, Bai Y, et al. A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway. British Journal Of Pharmacology. 2015;172(23):5573-5585. doi:10.1111/bph.13133.
  92. Chen G-Y, Shu Y-C, Chuang D-Y, Wang Y-C. Inflammatory and Apoptotic Regulatory Activity of Tanshinone IIA in Helicobacter pylori-Infected Cells. The American Journal Of Chinese Medicine. 2016;44(6):1187-1206. 
  93. Rui W, Xie L, Liu X, et al. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription. Journal Of Ethnopharmacology. 2014;151(1):198-209. doi:10.1016/j.jep.2013.10.022.

© Patrick Lynch LAc, MAOM, DAOM intern

Doctor of Acupuncture and Oriental Medicine, intern

Sky Ridge Acupuncture and Oriental Medicine

Leave a comment

Sky Ridge Acupuncture and Oriental Medicine

© Sky Ridge Acupuncture and Oriental Medicine